DE69527868T2 - Monoklonaler Antikörper gegen den tumorzytotoxischen Faktor II (TCF-II) - Google Patents

Monoklonaler Antikörper gegen den tumorzytotoxischen Faktor II (TCF-II)

Info

Publication number
DE69527868T2
DE69527868T2 DE69527868T DE69527868T DE69527868T2 DE 69527868 T2 DE69527868 T2 DE 69527868T2 DE 69527868 T DE69527868 T DE 69527868T DE 69527868 T DE69527868 T DE 69527868T DE 69527868 T2 DE69527868 T2 DE 69527868T2
Authority
DE
Germany
Prior art keywords
tcf
monoclonal antibody
antibody against
against tumor
cytotoxic factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69527868T
Other languages
English (en)
Other versions
DE69527868D1 (de
Inventor
Kanji Higashio
Nobuyuki Shima
Fumiko Oogaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atlas Pharmaceuticals Inc Sunnyvale Calif Us
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of DE69527868D1 publication Critical patent/DE69527868D1/de
Application granted granted Critical
Publication of DE69527868T2 publication Critical patent/DE69527868T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69527868T 1994-03-18 1995-03-17 Monoklonaler Antikörper gegen den tumorzytotoxischen Faktor II (TCF-II) Expired - Fee Related DE69527868T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6074263A JPH07258298A (ja) 1994-03-18 1994-03-18 モノクローナル抗体

Publications (2)

Publication Number Publication Date
DE69527868D1 DE69527868D1 (de) 2002-10-02
DE69527868T2 true DE69527868T2 (de) 2003-05-08

Family

ID=13542077

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69527868T Expired - Fee Related DE69527868T2 (de) 1994-03-18 1995-03-17 Monoklonaler Antikörper gegen den tumorzytotoxischen Faktor II (TCF-II)

Country Status (11)

Country Link
US (1) US5658742A (de)
EP (1) EP0672685B1 (de)
JP (1) JPH07258298A (de)
AT (1) ATE222927T1 (de)
AU (1) AU684132B2 (de)
CA (1) CA2145005C (de)
DE (1) DE69527868T2 (de)
DK (1) DK0672685T3 (de)
ES (1) ES2182867T3 (de)
NZ (1) NZ270743A (de)
ZA (1) ZA952125B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821223A (en) * 1990-09-14 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Method of stimulating cell growth with a novel broad spectrum human lung fibroblast-derived mitogen
JP4006058B2 (ja) * 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
ATE344050T1 (de) * 1997-03-14 2006-11-15 Daiichi Seiyaku Co Verwendung von tcf-ii zur behandlung von durch krebs verursachtem gewichtsverlust, anaemie und tnf-erhöhung
US6548296B1 (en) * 1997-07-23 2003-04-15 Roche Diagnostics Gmbh Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof
JP2003047470A (ja) * 2001-08-01 2003-02-18 Asahi Kasei Corp 新規な抗体及びその用途
US8575099B2 (en) * 2006-04-20 2013-11-05 Osaka University Agent for treating polyglutamine aggregation-caused disease or suppressing onset thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0597A (ja) * 1991-06-21 1993-01-08 Snow Brand Milk Prod Co Ltd 新規抗ｔｃｆ−ｉｉモノクローナル抗体及びそれを用いるｔｃｆ−ｉｉの測定方法

Also Published As

Publication number Publication date
AU1493995A (en) 1995-09-28
DE69527868D1 (de) 2002-10-02
AU684132B2 (en) 1997-12-04
ES2182867T3 (es) 2003-03-16
CA2145005C (en) 2005-06-21
JPH07258298A (ja) 1995-10-09
EP0672685A2 (de) 1995-09-20
ATE222927T1 (de) 2002-09-15
US5658742A (en) 1997-08-19
CA2145005A1 (en) 1995-09-19
EP0672685B1 (de) 2002-08-28
ZA952125B (en) 1995-12-14
DK0672685T3 (da) 2003-01-06
EP0672685A3 (de) 1997-01-15
NZ270743A (en) 1996-06-25

Similar Documents

Publication Publication Date Title
NL300238I2 (nl) Gehumaniseerde antilichamen tegen leukocytenadhesiemolecule VLA-4-
DE69429095T2 (de) Humanisierte antikoerper
DK0733069T3 (da) Oprensede Primat CTLA-8-antigener og beslægtede reagenser
AP2000001786A0 (en) Therapeutic uses of quinoline derivatives.
DE69531679D1 (de) Für e-selectin und p-selectin spezifische kreuzreaktive monoklonale antikörper
DK388384D0 (da) Monoklone antistoffer med specifitet for membran-associerede antigene, deres fremstilling og anvendelse
DK0713495T3 (da) Fremgangsmåder til forstærkning af den biologiske aktivitet af chemokiner
DE3689734D1 (de) Gereinigter immunoglobulinbezüglicher Faktor, monoklonale Antikörper, Hybridoma-Zellinien, Verfahren und Verwendungen.
IT8320550A0 (it) Procedimento di purificazione peraffinita' in cui si impiegano anticorpi monoclonali.
NO965239D0 (no) Monoklonalt antistoff mot CD44v6
ATE161582T1 (de) Monoklonale antikörper der maus
DE3482905D1 (de) Monoklonale antikoerper gegen lungenkrebs des "nicht-kleine-zellen"-typs.
ATE151078T1 (de) Verfahren und zwischenprodukte synthetischer antikörperderivate
ATE222927T1 (de) Monoklonaler antikörper gegen den tumorzytotoxischen faktor ii (tcf-ii)
ES2114547T3 (es) Anticuerpos monoclonales contra el virus de la hepatitis c.
DK176986A (da) Monoklonalt anti-urokinase-antistof og produktion og anvendelse deraf
DK0513565T3 (da) Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse
ATE136469T1 (de) Neue verwendung eines monoklonalen antikörpers

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOETERS & LIECK, 81541 MUENCHEN

8327 Change in the person/name/address of the patent owner

Owner name: ATLAS PHARMACEUTICALS, INC., SUNNYVALE, CALIF., US

8339 Ceased/non-payment of the annual fee